BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33045898)

  • 1. Continuous improvement on the rationality of prophylactic injectable PPIs usage by a clinical pharmacist-led guidance team at a Chinese tertiary teaching hospital.
    Hong Y; Ye Z; Gao Z; Rao Y
    J Int Med Res; 2020 Oct; 48(10):300060520954729. PubMed ID: 33045898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of continuous improvement by a clinical pharmacist-led guidance team on the prophylactic antibiotics usage rationality in intervention procedure at a Chinese tertiary teaching hospital.
    Yang P; Jiang SP; Lu XY
    Ther Clin Risk Manag; 2017; 13():469-476. PubMed ID: 28442914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in proton pump inhibitor prescribing trend over the past decade and pharmacists' effect on prescribing practice at a tertiary hospital.
    Luo H; Fan Q; Xiao S; Chen K
    BMC Health Serv Res; 2018 Jul; 18(1):537. PubMed ID: 29996830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Pharmacist-Led PDCA Cycle in Reducing Prescription Abandonment: An Action Research from China.
    Lv L; Sun Y; Yang B; Xin C; Zhang M
    Patient Prefer Adherence; 2023; 17():2145-2152. PubMed ID: 37663895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a clinical pharmacist-led guidance team on cancer pain therapy in China: a prospective multicenter cohort study.
    Chen J; Lu XY; Wang WJ; Shen B; Ye Y; Jiang H; Wang QS; Cheng B
    J Pain Symptom Manage; 2014 Oct; 48(4):500-9. PubMed ID: 24726204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of interventions targeting the inappropriate use of proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department.
    Zhang Y; Yang H; Kong J; Liu L; Ran L; Zhang X; Yun J; Gu Q
    J Clin Pharm Ther; 2021 Feb; 46(1):149-157. PubMed ID: 33015848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Intervention Increases Rational Use of Proton Pump Inhibitors in the General Surgery Department.
    Chen Q; Wang Q; Zhang Y
    Front Pharmacol; 2022; 13():864081. PubMed ID: 35548351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China.
    Luo H; Fan Q; Bian T; Li X; Chen K; Zhang Q; Wei Y; Xiao Y; Li Y
    BMC Health Serv Res; 2019 Nov; 19(1):880. PubMed ID: 31752835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Prophylactic Antibiotic Practice for Cardiothoracic Surgery by Pharmacists' Effects.
    Zhou L; Ma J; Gao J; Chen S; Bao J
    Medicine (Baltimore); 2016 Mar; 95(9):e2753. PubMed ID: 26945362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery.
    Bao J; Zhou L; Xu M; Ma J
    Expert Opin Drug Saf; 2023; 22(7):611-619. PubMed ID: 36714924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study.
    Liu P; Li G; Wu Q; Han M; Zhang C
    Perioper Med (Lond); 2024 Mar; 13(1):19. PubMed ID: 38486296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital.
    Xin C; Dong Z; Lin M; Li GH
    Patient Prefer Adherence; 2018; 12():21-26. PubMed ID: 29343945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clinical pharmacist interventions on inappropriate prophylactic acid suppressant use in hepatobiliary surgical patients undergoing elective operations.
    Luo H; Fan Q; Xiao S; Chen K
    PLoS One; 2017; 12(10):e0186302. PubMed ID: 29045435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.
    Liu Y; Zhu X; Li R; Zhang J; Zhang F
    BMJ Open; 2020 Nov; 10(11):e040473. PubMed ID: 33243802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacist-Led Impact on Inappropriate Albumin Utilization and Associated Costs in General Ward Patients.
    Buckley MS; Agarwal SK; Lansburg JM; Kopp BJ; Erstad BL
    Ann Pharmacother; 2021 Jan; 55(1):44-51. PubMed ID: 32578446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "Plan-Do-Check-Action" Plan Helps Improve the Quality of the "Standardized Training of Resident Physicians": An Analysis of the Results of the First Pass Rate.
    Tang B; Lin D; Zhang F; Yan M; Shao A
    Front Public Health; 2020; 8():598774. PubMed ID: 33708754
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacist's interventions on proton pump inhibitor prescriptions in a University Hospital].
    Skalli S; Bertin C; Charhon N; Mouchoux C; Huet E; Charpiat B; Janoly-Dumenil A
    J Pharm Belg; 2015 Jun; (2):20-9. PubMed ID: 26466506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A descriptive study on clinical department managers' cognition of the Plan-Do-Check-Act cycle and factors influencing their cognition.
    Zhong X; Wu X; Xie X; Zhou Q; Xu R; Wang J; He L; He Y; Qiu X
    BMC Med Educ; 2023 May; 23(1):294. PubMed ID: 37127607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.